Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today
Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") announced today that it has priced its previously announced public offering of 2.5 million of its 7.00% tangible equity
Biodesix, Inc. (NASDAQ:BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the pricing of an underwritten public offering of 30,500,000 shares of its common stock
Ormat Technologies, Inc. (NYSE:ORA) ("Ormat"), a leading geothermal, energy storage, solar PV and recovered energy power company, announced today the pricing of an upsized underwritten secondary offering of
DZS Inc. (NASDAQ:DZSI) (the "Company" or "DZS"), a global leader in access and optical edge infrastructure and cloud software solutions, today announced that it has priced an underwritten registered
Privia Health Group, Inc. (NASDAQ:PRVA, or ", Privia Health", or the ", Company", )))) announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of common stock by
Bionomics Limited ((ASX: BNO, NASDAQ:BNOX), ("Bionomics" or the "Company"), a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the
DZS Inc. (NASDAQ:DZSI) (the “Company” or “DZS”), a global leader in access and optical edge infrastructure and cloud software solutions, today announced the launch of an underwritten registered
SenesTech, Inc. (NASDAQ:SNES, ", , SenesTech", , or the ", , Company", , )))) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and